Dr. Teja Poosarla, MD

  • Chicago, IL
  • Medical oncologist
NPI1932467792PAC ID3173747920
Medicare services, 2024
399
Medicare patients, 2024
203
Part D claims, 2024
722
Publications
7
Clinical trials
5
Practice address
1430 Paysphere Cir, Chicago, IL 60674
Practice phone
Call (847) 731-4151
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Midwestern Regional Medical Center

Chicago, Illinois

See all 8 affiliations

Find Dr. Poosarla's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Teja Poosarla is a medical oncologist in Chicago, Illinois

Dr. Poosarla practices at Midwestern Regional Medical Center in Chicago, Illinois.

Dr. Poosarla's NPI, 1932467792, was assigned on May 1, 2012. Dr. Poosarla graduated from University of South Alabama College of Medicine in 2012. Dr. Poosarla holds Virginia license 0101273767.

NPI and contact details
Medicare PAC ID
3173747920
NPI enumeration date
May 1, 2012
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(847) 731-4151
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
40
Medical school graduation
2012

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Teja Poosarla practices at Midwestern Regional Medical Center in Chicago, Illinois

Dr. Poosarla's primary practice is Midwestern Regional Medical Center, at 1430 Paysphere Cir, Chicago, IL 60674 in Cook County. The practice phone is (847) 731-4151.

  • Midwestern Regional Medical Center
    1430 Paysphere Cir, Chicago, IL 60674 · Cook CountyPhone(847) 731-4151

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Teja Poosarla is affiliated with 4 sites of care and 4 medical groups

Dr. Poosarla's primary practice is Midwestern Regional Medical Center in Chicago, Illinois. Dr. Poosarla is also affiliated with City of Hope Cancer Center Chicago. The medical group on file is City of Hope Cancer Center Chicago. Dmand AI also links Dr. Poosarla to 3 more medical groups and 2 group practices and clinics, each named with a free account.

See all 8 affiliations for Dr. Poosarla

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Teja Poosarla's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poosarla practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Midwestern Regional Medical CenterAvailable with a free account
+3 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Poosarla practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Teja Poosarla is one of 153 medical oncologists in Illinois

Medical oncology is Dr. Poosarla's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Poosarla's licenses on file in 3 states: Virginia, Alabama and Mississippi.

Specialties and state licenses

  • Medical oncology, VirginiaPrimaryLicense 0101273767 · taxonomy 207RX0202X
  • Hematology and oncology, AlabamaLicense MD.37162 · taxonomy 207RH0003X
  • Mississippi licenseLicense 23858

Medical oncologists near Dr. Poosarla

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Teja Poosarla billed Medicare for 399 services in 2024

CMS data shows 399 Medicare services from Dr. Poosarla across 5 procedure codes in 2024, for 203 Medicare patients. Medicare paid $38,109 for them.

Medicare services, 2024399
Medicare patients203
Paid by Medicare$38,109
Procedure codes5

Dr. Poosarla's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2732024: 39946%

Where Dr. Poosarla's Medicare services took place, 2024

  • In an office30476%
  • In a facility9524%

Dr. Poosarla compared with the Illinois median for medical oncologists, 2024

  • Dr. Poosarla
  • Illinois median
Medicare services
399vs 67141% below
Medicare patients
203vs 23012% below
Part D claims
530vs 34554% above

Medians across 140 medical oncologists in Illinois with Dmand AI profiles that report each measure.

Dr. Poosarla's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Poosarla

Need commercial claims for Dr. Poosarla?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Poosarla and other medical oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Teja Poosarla treated 203 Medicare patients in 2024, average age 73

CMS counts 203 Medicare patients who saw Dr. Poosarla in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have cancer, and 74% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poosarla's median patient age at 66, with 97% women.

Medicare patients, 2024203
Average age73
Average risk score1.70
Also on Medicaid9%

Dr. Poosarla's Medicare patients by age, 2024

Dr. Poosarla's Medicare patients by sex, 2024

  • Women17988%
  • Men2412%

Chronic conditions among Dr. Poosarla's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol74%
  3. High blood pressure72%
  4. Arthritis44%
  5. Diabetes31%
  6. Osteoporosis31%
  7. Anxiety27%
  8. Chronic kidney disease27%

Share of Medicare patients with each condition. A patient can have several.

Dr. Poosarla's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women97%
  • Men3%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Teja Poosarla wrote 722 Medicare Part D claims in 2024

In 2024, Dr. Poosarla wrote 722 Medicare Part D claims for 149 patients. 95% of them were for generic drugs. CMS names the drug for 530 of them, across 10 drugs with 11 or more claims each, at $260,416 in total drug cost. In 2023, CMS named 203 claims across 5 drugs.

Part D claims, 2024722
Drugs named by CMS10
Total drug cost$260,416
Part D patients149

Dr. Poosarla's Part D claims by kind of drug, 2024

  • Generic684 claims95%
  • Brand-name38 claims5%

Dr. Poosarla's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2032024: 530161%

Drugs named by CMS: 10 in 2024, 5 in 2023.

See all prescribing by Dr. Poosarla

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Teja Poosarla scored 86 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Poosarla for performance year 2024, reported as part of a group. Dr. Poosarla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poosarla as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Poosarla's MIPS scores, performance year 2024

  • 86of 100Final score
  • 74.2of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 67of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Poosarla by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Teja Poosarla has 7 publications on record

Dmand AI links 7 papers to Dr. Poosarla, published from 2015 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Black or African American. Dr. Poosarla's most frequent co-authors are Nicolette P. Holliday, MD, Margaret Block, MD and Andrew Jacob Brenner, MD, PhD.

Papers7
Years published2015 to 2024

Dr. Poosarla's papers by year, 2015 to 2024

Topics Dr. Poosarla writes about most

  • Black or African American

Dr. Poosarla's most frequent co-authors

Recent publications by Dr. Poosarla

See all 7 publications and co-authors

See who Dr. Poosarla researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Poosarla works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Teja Poosarla has worked on 5 clinical trials

Dmand AI links Dr. Poosarla to 5 clinical trials. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Brain Neoplasms.

Clinical trials with Dr. Poosarla by phase

  1. NonePhase 1: no trials
  2. 1Phase 2: 1 trial
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Poosarla's trials

  • Breast Neoplasms
  • Breast Diseases
  • Brain Neoplasms
  • Triple Negative Breast Neoplasms
  • Central Nervous System Neoplasms

Investigators on the most trials with Dr. Poosarla

Recent clinical trials with Dr. Poosarla

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Teja Poosarla received $6,633 in industry payments from 2016 to 2025

CMS Open Payments shows 190 general payments to Dr. Poosarla from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 44% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,498.

General payments to Dr. Poosarla by program year, 2016 to 2025

General payments to Dr. Poosarla by kind, 2016 to 2025

$6.6Kin total
  • Food and beverage$2,90044%
  • Consulting fees$2,72341%
  • Education$70311%
  • Honoraria$1753%
  • Other$1322%

Companies that paid Dr. Poosarla the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Poosarla

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Teja Poosarla graduated from University of South Alabama College of Medicine

Dr. Poosarla graduated from University of South Alabama College of Medicine in 2012.

  1. Medical schoolUniversity of South Alabama College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Teja Poosarla's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Teja Poosarla

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Teja Poosarla's NPI number?

Dr. Teja Poosarla's NPI number is 1932467792. It was assigned on May 1, 2012, and it is active in the NPI Registry.

What kind of doctor is Dr. Teja Poosarla?

Dr. Teja Poosarla is a medical oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Teja Poosarla practice?

Dr. Poosarla practices at 1430 Paysphere Cir, Chicago, IL 60674. Dr. Poosarla's primary practice is Midwestern Regional Medical Center in Chicago, Illinois. Dmand AI also links Dr. Poosarla to 3 medical groups and 2 group practices and clinics.

What is Dr. Teja Poosarla's office phone number?

The practice phone on file for Dr. Poosarla is (847) 731-4151.

What is Dr. Teja Poosarla's medical license number?

Dr. Poosarla holds Virginia license 0101273767, one of the licenses on file in 3 states.

Which states has Dr. Teja Poosarla been licensed in?

Dmand AI has state licenses on file for Dr. Poosarla in Virginia, Alabama and Mississippi.

Which hospitals is Dr. Teja Poosarla affiliated with?

Dr. Poosarla is affiliated with City of Hope Cancer Center Chicago.

What medical group is Dr. Teja Poosarla part of?

Dr. Poosarla is linked to City of Hope Cancer Center Chicago. Dmand AI links Dr. Poosarla to 3 more medical groups.

Does Dr. Teja Poosarla accept Medicare?

Yes. CMS data shows Dr. Poosarla billed Medicare for 399 services in 2024, and Dr. Poosarla accepts Medicare assignment.

Does Dr. Teja Poosarla offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Poosarla as offering telehealth services.

Show 9 more questionsShow fewer questions

What is Dr. Teja Poosarla's MIPS score?

Dr. Poosarla's MIPS final score for performance year 2024 is 86 out of 100, reported as part of a group.

How many Medicare patients does Dr. Teja Poosarla see?

CMS counts 203 Medicare patients who saw Dr. Poosarla in 2024, with an average age of 73.

What services does Dr. Teja Poosarla bill to Medicare?

In 2024, Dr. Poosarla's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, new patient (99205).

Where did Dr. Teja Poosarla go to medical school?

Dr. Poosarla graduated from University of South Alabama College of Medicine in 2012.

What drugs does Dr. Teja Poosarla prescribe most?

In 2024 Medicare Part D data, Dr. Poosarla's most prescribed drugs by claims were Letrozole, Anastrozole and Tamoxifen Citrate.

Has Dr. Teja Poosarla received payments from drug or device companies?

CMS Open Payments shows $6,633 in general payments to Dr. Poosarla from 35 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Teja Poosarla been practicing?

Dr. Poosarla graduated from medical school in 2012, 14 years ago.

Does Dr. Teja Poosarla do research?

Dmand AI links 7 publications to Dr. Poosarla, published from 2015 to 2024. Dr. Poosarla has worked on 5 clinical trials.

Who does Dr. Teja Poosarla publish with?

Dr. Poosarla's most frequent co-authors are Nicolette P. Holliday, MD (3 shared papers), Margaret Block, MD (1 shared paper) and Andrew Jacob Brenner, MD, PhD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)